Role of vascular normalization in benefit from metronomic chemotherapy
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Significance: Metronomic dosing has been proposed as an alternative to maximum tolerated doses of chemotherapy. Even though this strategy has shown promise in improving therapeutic outcomes in some cases, the underlying mechanisms of action are not fully understood. In this study, using mathematical modeling, we show that metronomic chemotherapy could be beneficial by normalizing tumor blood vessel function and improving tumor perfusion. Improved perfusion enhances the delivery of drugs to solid tumors and alleviates hypoxia. These effects also result in an improved immune response, contributing to increased killing of cancer cells, including more resistant cancer stem-like cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Certain molecularly targeted agents, such as the anti-HER2 antibody trastuzumab, and metronomic chemotherapy can also induce vascular normalization via upregulation of thrombospondin expression28,116,117.”
From Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges (2018) · cites this paper as [117]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527 · cited 6×
“Furthermore, in previous work (7) we showed that an increase in TSP-1 led to normalization of the tumor vessels, characterized by decreases in vascular permeability and diameter accompanied by an increase in functional vessel density (12, 15, 44).”
BackgroundInfluentialSelf-citationRegulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438 · cited 2×
“In our previous studies, we related vessel functionality to the permeability and compression of tumor vessels (37, 48, 51).”
MethodSelf-citationDrug delivery with carbon nanotubes for in vivo cancer treatment
Liu, Z., Chen, K., Davis, C. R., Sherlock, S. P., Cao, Q., Chen, X. S., & Dai, H. (2008) · PubMed · doi:10.48550/arxiv.0808.2070 · Cited by 2,286
Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
Jain, R. K. (2001) · Nature Medicine · doi:10.1038/nm0901-987 · Cited by 2,184 · cited 2×
“Vessel normalization repairs the structure and function of the tumor vessel wall and tumor vascular network, and can improve tumor perfusion and oxygenation (12, 15).”
BackgroundSelf-citationAnalysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma
Liu, G., Yuan, X., Zeng, Z., Tunici, P., Ng, H., Abdulkadir, I. R., Lu, L., Irvin, D., Black, K. L., & Yu, J. S. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-67 · Cited by 1,790
Browder, T. D., Butterfield, C., Kräling, B. M., Shi, B., Marshall, B., OʼReilly, M., & Folkman, J. (2000) · PubMed · Cited by 1,720
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
Jain, R. K. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.006 · Cited by 1,589 · cited 10×
“This change alone can cause tumor regression without changes in NK or CD8 cells (6).”
BackgroundInfluentialSelf-citationThe anti-angiogenic basis of metronomic chemotherapy
Kerbel, R. S., & Kamen, B. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1369 · Cited by 1,397 · cited 2×
“Am J Physiol Heart Circ Physiol 281(3):H1015–H1025.”
Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
Jain, R. K. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.3653 · Cited by 1,248 · cited 3×
“Modulation of other molecules, such as a decrease in VEGF level, also can induce vascular normalization (6, 44).”
BackgroundSelf-citationGhiringhelli, F., Menard, C., Puig, P. E., Ladoire, S., Roux, S., Martin, F., Solary, E., Le Cesne, A., Zitvogel, L., & Chauffert, B. (2007) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-006-0225-8 · Cited by 1,241
Cited by
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
Fukumura, D., Kloepper, J., Amoozgar, Z., Duda, D. G., & Jain, R. K. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.29 · Cited by 2,027
Self-citationInnovative Strategies for Hypoxic‐Tumor Photodynamic Therapy
Li, X., Kwon, N., Guo, T., Liu, Z., & Yoon, J. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201805138 · Cited by 1,175
Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
Martin, J. D., Cabral, H., Stylianopoulos, T., & Jain, R. K. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0308-z · Cited by 682
Self-citationStylianopoulos, T., Munn, L. L., & Jain, R. K. (2018) · Trends in Cancer · doi:10.1016/j.trecan.2018.02.005 · Cited by 563
Self-citationNormalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges
Martin, J. D., Seano, G., & Jain, R. K. (2019) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114700 · Cited by 530
“—Thrombospondin-1 (TSP-1) was recognized as the first endogenous antiangiogenic growth factor and has been studied in the treatment of multiple cancers (103).”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- Mpekris, F., Baish, J. W., Stylianopoulos, T., & Jain, R. K.
- Affiliations
- University of Cyprus (CY)
- Bucknell University (US)
- Harvard University (US)
- Corresponding author
- Jain, Rakesh K.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2017-02-07
- Volume
- 114
- Issue
- 8
- Pages
- 1994-1999
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC5338413
- OpenAlex
- W2586781596
- Cited by
- 178
- References
- 64
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 14 · 2023: 20 · 2022: 22 · 2021: 26 · 2020: 26 · 2019: 17 · 2018: 17 · 2017: 6
- FWCI
- 13.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Bucknell Digital Commons (Bucknell University) (submittedVersion)
- Funders
- EC | European Research Council (336839)
- HHS | NIH | National Cancer Institute (P01-CA080124)
- Topics
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- metronomic chemotherapy, vascular normalization, tumor vasculature, tumor perfusion, tumor hypoxia, tumor microenvironment, immunosuppression, regulatory T cells, cancer stem-like cells, tumor growth modeling, drug delivery, dosing regimen, positive feedback loop
- MeSH terms
- Animals, Antineoplastic Combined Chemotherapy Protocols, Humans, Models, Theoretical, Neoplasms, Neovascularization, Pathologic, Neoplastic Stem Cells, Cell Hypoxia, Thrombospondin 1, Xenograft Model Antitumor Assays, Tumor Microenvironment, Administration, Metronomic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of vascular normalization in benefit from metronomic chemotherapy. https://app.cochat.ai/papers/10.1073/pnas.1700340114
- The paper
- Mpekris, F., Baish, J. W., Stylianopoulos, T., & Jain, R. K. (2017). Role of vascular normalization in benefit from metronomic chemotherapy. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1700340114
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.